Genetic risk for Alzheimer’s disease is concentrated in specific macrophage and microglial transcriptional networks
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-994X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Genetic risk for Alzheimer’s disease is concentrated in specific macrophage and microglial transcriptional networks ; volume:10 ; number:1 ; day:26 ; month:2 ; year:2018 ; pages:1-10 ; date:12.2018
Genome medicine ; 10, Heft 1 (26.2.2018), 1-10, 12.2018
- Creator
-
Tansey, Katherine E.
- Contributor
-
Cameron, Darren
Hill, Matthew J.
SpringerLink (Online service)
- DOI
-
10.1186/s13073-018-0523-8
- URN
-
urn:nbn:de:1111-201804251150
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tansey, Katherine E.
- Cameron, Darren
- Hill, Matthew J.
- SpringerLink (Online service)
Other Objects (12)
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology
Microglial Activation in Alzheimer’s Disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Müller cell degeneration and microglial dysfunction in the Alzheimer’s retina
Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
Phosphoinositides signaling modulates microglial actin remodeling and phagocytosis in Alzheimer’s disease
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
Role of dietary fatty acids in microglial polarization in Alzheimer’s disease
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology
Microglial Activation in Alzheimer’s Disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Müller cell degeneration and microglial dysfunction in the Alzheimer’s retina
Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
Phosphoinositides signaling modulates microglial actin remodeling and phagocytosis in Alzheimer’s disease
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
Role of dietary fatty acids in microglial polarization in Alzheimer’s disease
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology
Microglial Activation in Alzheimer’s Disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Müller cell degeneration and microglial dysfunction in the Alzheimer’s retina
Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
Phosphoinositides signaling modulates microglial actin remodeling and phagocytosis in Alzheimer’s disease
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology